Here are five most-read stories this year:
1. 91 patients treated for TB after spine surgery with infected allograft
2. Bioventus to acquire spine company for $518M
3. Stem cell sales skyrocket despite lacking FDA approval, study finds
4. Medtronic terminates deal to distribute Aziyo’s cellular bone matrix products
5. Regenerative implant for lumbar spine surgery gets FDA breakthrough designation
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.